Keel Infrastructure Corp. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Keel Infrastructure Corp. Common Stock trades at $3.08 (market cap $1.93B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.68 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 30.4× Keel Infrastructure Corp. Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while Keel Infrastructure Corp. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Keel Infrastructure Corp. Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| KEEL | TAK | |
|---|---|---|
Market Cap | $1.93B | $58.74B |
Volume | 30,868,523 | 3,110,994 |
Sector | Technology | Health |
52-Week High | $6.66 | $19.05 |
52-Week Low | $1.71 | $13.23 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $2.25B | $86.65B |
Dividend Yield | — | 3.33% |
Trailing returns across standard periods
Latest headlines on both assets
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →